semaglutide
App‑Supported Obesity Treatment vs Traditional Care - Here’s the Evidence‑Based Verdict
Oral GLP-1 therapies lead to substantial weight loss, delivering about a 16-21% reduction in body weight across major trials. In the OASIS 4 study, Wegovy’s pill achieved a mean 16.6% loss, while the higher-dose injectable Wegovy HD reached 20.7% (Novo Nordisk). These results show oral agents can